Search results
Showing results for
The University of Oxford and Bayer HealthCare have entered into a strategic research alliance in the area of gynaecological therapies. The multi-target collaboration focuses on endometriosis and uterine fibroids with the goal of discovering and developing innovative treatment options for these diseases. The alliance is for an initial period of two years, but is open for extension to up to five years.
©
Shutterstock
OxLuPIn Study
The OxLuPIn study (Oxford Luteal Dysfunction and Placental Insufficiency) is looking for women aged 16 years or older, who are less than 8 weeks’ pregnant, to help us understand early pregnancy and how to better predict complications such as high blood pressure later on.